COA on Every ProductUSP Certified MaterialsProudly Canadian ManufacturerAll Excipients: USP-Grade ◆ Low Endotoxin ◆ Low MetalRaw Materials Sourced from GMP-Manufacturing FacilitiesCOA on Every ProductUSP Certified MaterialsProudly Canadian ManufacturerAll Excipients: USP-Grade ◆ Low Endotoxin ◆ Low MetalRaw Materials Sourced from GMP-Manufacturing Facilities
CJC-1295 + Ipamorelin 20 mg
CJC-1295 + Ipamorelin 20 mg - Image 2

CJC-1295 + Ipamorelin 20 mg

CJC-1295 and Ipamorelin blend, 20 mg – a GHRH analog paired with a selective growth-hormone secretagogue. For research purposes only.

🇨🇦 Canadian First Lyfe is the first manufacturer of dual chamber pens in Canada. Learn More →

Description

A blend of CJC-1295, a growth-hormone-releasing hormone (GHRH) analog, and Ipamorelin, a selective ghrelin-receptor agonist. The two act on complementary pathways and are frequently paired in secretagogue research.

Commonly explored in research for:

  • Synergistic growth-hormone release from two mechanisms
  • Pulsatile GH secretion and IGF-1 axis models
  • Ghrelin-receptor (GHS-R) and GHRH-receptor signalling
  • Body-composition and metabolic research models

Supplied as 20 mg lyophilized powder; also available loaded in the Lyfe pen.

⚖️

Chemical Overview

Key identifiers & structural data

🔬 Structural Data

About Ipamorelin

Classificationstr
CAS Registry170851-70-4
Molecular Mass711.9
Residue Countstr
Chain SequenceAib-His-D-2-Nal
Molecular FormulaC38H49N9O5
🔗 View on PubChem
📑

Research Literature

Published studies & clinical data

Growth Hormone & IGF Research

Ipamorelin: A selective growth hormone secretagogue

2000 • PMID: 10876026

Raun K, Hansen BS, Johansen NL

Read Paper ↗
Journal of Endocrinology

Effects of ipamorelin on growth hormone release

2001 • PMID: 11312142

Jaspers C, Raun K, Hansen BS

Read Paper ↗
Clinical Endocrinology

Ipamorelin: Clinical applications

2002 • PMID: 12030819

Johansen NL, Hansen BS, Raun K

Read Paper ↗

Related products